MiMedx Group Announces Commercial Launch Of HELIOGEN Fibrillar Collagen Matrix, A Particulate Xenograft Product For Complex Surgical Wounds; HELIOGEN Contains Type I And Type III Collagen And Mimics Native Structural Connective Tissue
MiMedx Group Announces Commercial Launch Of HELIOGEN Fibrillar Collagen Matrix, A Particulate Xenograft Product For Complex Surgical Wounds; HELIOGEN Contains Type I And Type III Collagen And Mimics Native Structural Connective Tissue
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.